Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew E. Korenberg currently holds 44,060 shares of LIGAND PHARMACEUTICALS INC (LGND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew E. Korenberg has been a net seller of LGND stock. They have purchased $43.1K and sold $12.6M worth of shares.
Matthew E. Korenberg's most recent insider trade was on Jul 15, 2025, when they sold 19,506 shares at $0.00 per share.
Matthew E. Korenberg serves as Executive at LIGAND PHARMACEUTICALS INC (LGND). They have executed 104 insider transactions totaling $12.6M over their tenure at the company.
Matthew E. Korenberg holds the position of Executive at LIGAND PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Matthew E. Korenberg has shown a selling trading pattern, with $43.1K in total purchases and $12.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Matthew E. Korenberg was on Aug 9, 2024, when they sold $1.8M worth of LGND shares. This transaction involved 18,245 shares at $98.50 per share.
Matthew E. Korenberg currently owns 44,060 shares of LIGAND PHARMACEUTICALS INC (LGND), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew E. Korenberg's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew E. Korenberg has 104 Form 4 filings on record as an insider at LIGAND PHARMACEUTICALS INC.
Set alerts for Matthew E. Korenberg and 40,000+ other insiders.